# Ezetimibe Utilization Early After Acute Myocardial Infarction, "EzAMI Trial"

> **NCT04701242** · NA · RECRUITING · sponsor: **Cairo University** · enrollment: 500 (estimated)

## Conditions studied

- Acute Myocardial Infarction
- Dyslipidemias

## Interventions

- **DRUG:** Ezetimibe 10mg

## Key facts

- **NCT ID:** NCT04701242
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-03-24
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2024-08-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04701242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04701242, "Ezetimibe Utilization Early After Acute Myocardial Infarction, "EzAMI Trial"". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04701242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*